89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT
Rosar F, Bartholomä M, Maus S, Privé BM, Khreish F, Franssen GM, Derks YH, Nagarajah J, Ezziddin S (2022)
Publication Type: Journal article
Publication year: 2022
Journal
Book Volume: 47
Pages Range: 435-436
Journal Issue: 5
DOI: 10.1097/RLU.0000000000004108
Abstract
For localization of biochemical recurrence of prostate cancer, 68Ga-PSMA-11 PET/CT imaging was performed in a 66-year-old man with no suspicious findings at 1 hour p.i. Additional 89Zr-PSMA-617 PET/CT revealed a small local recurrence in the prostate bed, facilitating consecutive local therapy. This interesting image points to the potential of PET/CT with 89Zr-labeled PSMA ligands, for example, 89Zr-PSMA-617, for identifying the source of biochemical recurrence despite otherwise negative imaging including conventional PSMA PET/CT.
Involved external institutions
Universitätsklinikum des Saarlandes (UKS)
Germany (DE)
Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC)
Netherlands (NL)
Germany (DE)
Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC)
Netherlands (NL)
How to cite
APA:
Rosar, F., Bartholomä, M., Maus, S., Privé, B.M., Khreish, F., Franssen, G.M.,... Ezziddin, S. (2022). 89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT. Clinical Nuclear Medicine, 47(5), 435-436. https://doi.org/10.1097/RLU.0000000000004108
MLA:
Rosar, Florian, et al. "89Zr-PSMA-617 PET/CT May Reveal Local Recurrence of Prostate Cancer Unidentified by 68Ga-PSMA-11 PET/CT." Clinical Nuclear Medicine 47.5 (2022): 435-436.
BibTeX: Download